comparemela.com

Latest Breaking News On - Frank michalargias - Page 2 : comparemela.com

Helix Biopharma : Announces Extension of Early Warrant Exercise Incentive Program and Receipt of Private Placement Subscription

RICHMOND, ON / ACCESSWIRE / April 13, 2022 / Helix BioPharma Corp. , a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on its. | April 13, 2022

Helix BioPharma Corp : Helix Announces Board Resignation

RICHMOND HILL, ON / ACCESSWIRE / April 7, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology

NA Proactive news snapshot: Kontrol Technologies Corp, Imperial Helium Corp, Emmaus Life Sciences Inc, ACME Lithium Inc, Fabled Copper Corp UPDATE

NA Proactive news snapshot: Kontrol Technologies Corp, Imperial Helium Corp, Emmaus Life Sciences Inc, ACME Lithium Inc, Fabled Copper Corp UPDATE
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

NA Proactive news snapshot: Gevo Inc, Deep-South Resources Inc, Context Therapeutics Inc, Phunware Inc, Kontrol Technologies Corp, Imperial Helium Corp, Emmaus Life Sciences Inc, ACME Lithium Inc, Fabled Copper Corp UPDATE

NA Proactive news snapshot: Gevo Inc, Deep-South Resources Inc, Context Therapeutics Inc, Phunware Inc, Kontrol Technologies Corp, Imperial Helium Corp, Emmaus Life Sciences Inc, ACME Lithium Inc, Fabled Copper Corp UPDATE
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Helix BioPharma Corp : Helix Biopharma Corp Announces Management and Board Changes

RICHMOND HILL, ON / ACCESSWIRE / March 22, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.